DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas. 1987

D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert

The prognostic value of parameters as determined by DNA flow cytometry, in combination with other parameters, was assessed in 75 patients with ovarian carcinomas (20% in stage I and II). DNA- index of the tumours appeared to predict mainly the degree of differentiation, since the DNA-index only tended to affect prognosis and low grade tumours were mainly diploid. However, with ascites a non-diploid DNA-index was associated with a significantly lower survival in short-term follow-up. Subgroups with a favourable prognosis were defined by an age of patients less than or equal to 40 years, grade 1 tumours, and tumours in stage I or II. Particularly favourable was the combination of a grade 1 tumour, or a tumour in stage I or II, with percentage of cells in G1 greater than 85%. Prognostically poor subgroups were defined by an age greater than 60 years, by grade 2 or 3 tumours and by a clinically advanced stage. The combination of grade 2 or 3, or a clinically advanced stage, with G1-phase fraction less than or equal to 85% identified subgroups with a particularly poor prognosis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
January 1994, Anticancer research,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
February 1993, Gynecologic oncology,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
September 1987, British journal of urology,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
September 1993, Gynecologic oncology,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
June 1990, Southern medical journal,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
October 1998, Gynecologic oncology,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
June 1989, Gynecologic oncology,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
January 1992, Acta obstetricia et gynecologica Scandinavica. Supplement,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
April 2002, Klinicheskaia laboratornaia diagnostika,
D H Rutgers, and I S Wils, and A H Schaap, and A C van Lindert
March 1992, The European journal of surgery = Acta chirurgica,
Copied contents to your clipboard!